These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35667282)

  • 1. Interleukin-36α is elevated in diffuse systemic sclerosis and may potentiate fibrosis.
    O'Reilly S
    Cytokine; 2022 Aug; 156():155921. PubMed ID: 35667282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated interleukin-11 in systemic sclerosis and role in disease pathogenesis.
    Steadman T; O'Reilly S
    J Dermatol; 2023 Oct; 50(10):1255-1261. PubMed ID: 37291792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis.
    Freedman P; Schock B; O'Reilly S
    Cells; 2024 Jul; 13(14):. PubMed ID: 39056787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.
    Brembilla NC; Dufour AM; Alvarez M; Hugues S; Montanari E; Truchetet ME; Lonati P; Fontao L; Gabrielli A; Vettori S; Valentini G; Boehncke WH; Meroni P; Chizzolini C
    Ann Rheum Dis; 2016 Sep; 75(9):1697-705. PubMed ID: 26452537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of interleukin 1 family with systemic sclerosis.
    Zhang L; Yan JW; Wang YJ; Wan YN; Wang BX; Tao JH; Chen B; Li BZ; Yang GJ; Wang J
    Inflammation; 2014 Aug; 37(4):1213-20. PubMed ID: 24531856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis.
    Truchetet ME; Demoures B; Eduardo Guimaraes J; Bertrand A; Laurent P; Jolivel V; Douchet I; Jacquemin C; Khoryati L; Duffau P; Lazaro E; Richez C; Seneschal J; Doutre MS; Pellegrin JL; Constans J; Schaeverbeke T; Blanco P; Contin-Bordes C;
    Arthritis Rheumatol; 2016 Nov; 68(11):2784-2794. PubMed ID: 27429171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response.
    Masui Y; Asano Y; Shibata S; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
    Rheumatology (Oxford); 2013 Jul; 52(7):1239-44. PubMed ID: 23443327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis.
    Kudo H; Jinnin M; Asano Y; Trojanowska M; Nakayama W; Inoue K; Honda N; Kajihara I; Makino K; Fukushima S; Ihn H
    Arthritis Rheumatol; 2014 Jun; 66(6):1636-47. PubMed ID: 24470401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis.
    Gasparini G; Cozzani E; Parodi A
    Cytokine; 2020 Jan; 125():154799. PubMed ID: 31400638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis.
    Russo B; Borowczyk J; Cacialli P; Moguelet P; Truchetet ME; Modarressi A; Brembilla NC; Bertrand J; Boehncke WH; Chizzolini C
    Rheumatology (Oxford); 2022 Nov; 61(11):4558-4569. PubMed ID: 35171244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis.
    Xu D; Mu R; Wei X
    Front Immunol; 2019; 10():2025. PubMed ID: 31572353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin (IL)-17F and IL-17E are related to fibrosis and vasculopathy in systemic sclerosis.
    Fukayama M; Yoshizaki A; Fukasawa T; Ebata S; Kuzumi A; Yoshizaki-Ogawa A; Asano Y; Oba K; Sato S
    J Dermatol; 2020 Nov; 47(11):1287-1292. PubMed ID: 32686186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis.
    Baker Frost D; Savchenko A; Takamura N; Wolf B; Fierkens R; King K; Feghali-Bostwick C
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA27a-3p mediates reduction of the Wnt antagonist sFRP-1 in systemic sclerosis.
    Henderson J; Wilkinson S; Przyborski S; Stratton R; O'Reilly S
    Epigenetics; 2021; 16(7):808-817. PubMed ID: 32965161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
    Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
    Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
    Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
    Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
    McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
    Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.